These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17135364)
21. [Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line]. Wang LH; Rao Q; Wang M; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):449-52. PubMed ID: 16383232 [TBL] [Abstract][Full Text] [Related]
22. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209 [TBL] [Abstract][Full Text] [Related]
23. Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Wang Y; Mandal D; Wang S; Kleinerman ES; Pollock RE; Lev D; Hayes-Jordan A Cancer; 2010 Aug; 116(16):3892-902. PubMed ID: 20564078 [TBL] [Abstract][Full Text] [Related]
24. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo. Irsan I; Akisue T; Hara H; Fujimoto T; Imabori M; Doita M; Kuroda R; Fujioka H; Kawamoto T; Yamamoto T; Kurosaka M Anticancer Res; 2007; 27(1A):423-9. PubMed ID: 17352263 [TBL] [Abstract][Full Text] [Related]
25. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro. Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551 [TBL] [Abstract][Full Text] [Related]
27. Imatinib resistance in multidrug-resistant K562 human leukemic cells. Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528 [TBL] [Abstract][Full Text] [Related]
28. Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro. Mokhtari D; Li T; Lu T; Welsh N PLoS One; 2011; 6(9):e24831. PubMed ID: 21935477 [TBL] [Abstract][Full Text] [Related]
29. A defect in cell death of macrophages is a conserved feature of nonobese diabetic mouse. Kim HS; Park JM; Lee MS Biochem Biophys Res Commun; 2012 Apr; 421(1):145-51. PubMed ID: 22510411 [TBL] [Abstract][Full Text] [Related]
30. Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. Esparza-López J; Medina-Franco H; Escobar-Arriaga E; León-Rodríguez E; Zentella-Dehesa A; Ibarra-Sánchez MJ J Cancer Res Clin Oncol; 2013 Oct; 139(10):1625-35. PubMed ID: 23892407 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of the nuclear factor-κB subunit c-Rel protects against human islet cell death in vitro. Mokhtari D; Barbu A; Mehmeti I; Vercamer C; Welsh N Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1067-77. PubMed ID: 19706790 [TBL] [Abstract][Full Text] [Related]
32. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes. Mellado-Gil J; Rosa TC; Demirci C; Gonzalez-Pertusa JA; Velazquez-Garcia S; Ernst S; Valle S; Vasavada RC; Stewart AF; Alonso LC; Garcia-Ocaña A Diabetes; 2011 Feb; 60(2):525-36. PubMed ID: 20980460 [TBL] [Abstract][Full Text] [Related]
33. The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro. Meyerovich K; Fukaya M; Terra LF; Ortis F; Eizirik DL; Cardozo AK Diabetologia; 2016 Mar; 59(3):512-21. PubMed ID: 26634571 [TBL] [Abstract][Full Text] [Related]
34. Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells. Kim E; Matsuse M; Saenko V; Suzuki K; Ohtsuru A; Mitsutake N; Yamashita S Thyroid; 2012 Jul; 22(7):717-24. PubMed ID: 22650230 [TBL] [Abstract][Full Text] [Related]
35. C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2. Xia CQ; Zhang P; Li S; Yuan L; Xia T; Xie C; Clare-Salzler MJ PLoS One; 2014; 9(5):e97694. PubMed ID: 24835010 [TBL] [Abstract][Full Text] [Related]
36. In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib. Timeus F; Crescenzio N; Doria A; Foglia L; Pagliano S; Ricotti E; Fagioli F; Tovo PA; Cordero di Montezemolo L Oncol Rep; 2012 Mar; 27(3):734-40. PubMed ID: 22159894 [TBL] [Abstract][Full Text] [Related]
37. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217 [TBL] [Abstract][Full Text] [Related]
38. Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced β-cell damage and the development of type 1 diabetes. Bae UJ; Jang HY; Lim JM; Hua L; Ryu JH; Park BH Exp Mol Med; 2015 Apr; 47(4):e160. PubMed ID: 25907110 [TBL] [Abstract][Full Text] [Related]
39. Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Han MS; Chung KW; Cheon HG; Rhee SD; Yoon CH; Lee MK; Kim KW; Lee MS Diabetes; 2009 Feb; 58(2):329-36. PubMed ID: 19171749 [TBL] [Abstract][Full Text] [Related]
40. Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK. Elksnis A; Schiffer TA; Palm F; Wang Y; Cen J; Turpaev K; Ngamjariyawat A; Younis S; Huang S; Shen Y; Leng Y; Bergsten P; Karlsborn T; Welsh N; Wang X Clin Sci (Lond); 2021 Oct; 135(19):2243-2263. PubMed ID: 34569605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]